Literature DB >> 29556843

Progression of Colorectal Cancer Liver Metastasis After Chemotherapy: A New Test of Time?

Eve Simoneau1, Jean-Nicolas Vauthey2.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29556843      PMCID： PMC5930027          DOI： 10.1245/s10434-018-6439-0

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  13 in total

1.  The initial change in tumor size predicts response and survival in patients with metastatic colorectal cancer treated with combination chemotherapy.

Authors:  C Suzuki; L Blomqvist; A Sundin; H Jacobsson; P Byström; Å Berglund; P Nygren; B Glimelius
Journal:  Ann Oncol       Date:  2011-08-10       Impact factor: 32.976

2.  Progression while receiving preoperative chemotherapy should not be an absolute contraindication to liver resection for colorectal metastases.

Authors:  Luca Viganò; Lorenzo Capussotti; Eduardo Barroso; Gennaro Nuzzo; Christophe Laurent; Jan N M Ijzermans; Jean-François Gigot; Joan Figueras; Thomas Gruenberger; Darius F Mirza; Dominique Elias; Graeme Poston; Christian Letoublon; Helena Isoniemi; Javier Herrera; Francisco Castro Sousa; Fernando Pardo; Valerio Lucidi; Irinel Popescu; René Adam
Journal:  Ann Surg Oncol       Date:  2012-05-24       Impact factor: 5.344

3.  Hepatectomy for liver metastases.

Authors:  J Scheele
Journal:  Br J Surg       Date:  1993-03       Impact factor: 6.939

4.  Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases?

Authors:  René Adam; Gerard Pascal; Denis Castaing; Daniel Azoulay; Valerie Delvart; Bernard Paule; Francis Levi; Henri Bismuth
Journal:  Ann Surg       Date:  2004-12       Impact factor: 12.969

5.  Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases.

Authors:  Yun Shin Chun; Jean-Nicolas Vauthey; Piyaporn Boonsirikamchai; Dipen M Maru; Scott Kopetz; Martin Palavecino; Steven A Curley; Eddie K Abdalla; Harmeet Kaur; Chusilp Charnsangavej; Evelyne M Loyer
Journal:  JAMA       Date:  2009-12-02       Impact factor: 56.272

6.  Optimal morphologic response to preoperative chemotherapy: an alternate outcome end point before resection of hepatic colorectal metastases.

Authors:  Junichi Shindoh; Evelyne M Loyer; Scott Kopetz; Piyaporn Boonsirikamchai; Dipen M Maru; Yun Shin Chun; Giuseppe Zimmitti; Steven A Curley; Chusilp Charnsangavej; Thomas A Aloia; Jean-Nicolas Vauthey
Journal:  J Clin Oncol       Date:  2012-11-13       Impact factor: 44.544

7.  Progression of Colorectal Liver Metastases from the End of Chemotherapy to Resection: A New Contraindication to Surgery?

Authors:  Luca Vigano; Shadya Sara Darwish; Lorenza Rimassa; Matteo Cimino; Carlo Carnaghi; Matteo Donadon; Fabio Procopio; Nicola Personeni; Daniele Del Fabbro; Armando Santoro; Guido Torzilli
Journal:  Ann Surg Oncol       Date:  2018-02-27       Impact factor: 5.344

8.  Bevacizumab, capecitabine, and oxaliplatin as neoadjuvant therapy for patients with potentially curable metastatic colorectal cancer.

Authors:  Brigit Gruenberger; Dietmar Tamandl; Johannes Schueller; Werner Scheithauer; Christoph Zielinski; Friedrich Herbst; Thomas Gruenberger
Journal:  J Clin Oncol       Date:  2008-04-10       Impact factor: 44.544

9.  RAS mutations predict radiologic and pathologic response in patients treated with chemotherapy before resection of colorectal liver metastases.

Authors:  Giuseppe Zimmitti; Junichi Shindoh; Yoshihiro Mise; Scott Kopetz; Evelyne M Loyer; Andreas Andreou; Amanda B Cooper; Harmeet Kaur; Thomas A Aloia; Dipen M Maru; Jean-Nicolas Vauthey
Journal:  Ann Surg Oncol       Date:  2014-09-17       Impact factor: 5.344

10.  Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases.

Authors:  Sophia Frentzas; Eve Simoneau; Victoria L Bridgeman; Peter B Vermeulen; Shane Foo; Eleftherios Kostaras; Mark Nathan; Andrew Wotherspoon; Zu-Hua Gao; Yu Shi; Gert Van den Eynden; Frances Daley; Clare Peckitt; Xianming Tan; Ayat Salman; Anthoula Lazaris; Patrycja Gazinska; Tracy J Berg; Zak Eltahir; Laila Ritsma; Jacco Van Rheenen; Alla Khashper; Gina Brown; Hanna Nystrom; Malin Sund; Steven Van Laere; Evelyne Loyer; Luc Dirix; David Cunningham; Peter Metrakos; Andrew R Reynolds
Journal:  Nat Med       Date:  2016-10-17       Impact factor: 53.440
View more
  2 in total

1.  The expression of long non-coding RNA HOTAIR in advanced hepatocellular carcinoma and its prognostic correlation with sunitinib therapy.

Authors:  Chenyang Han; Yi Yang; Li Guo; Qiaobing Guan; Shuiliang Ruan
Journal:  Arch Med Sci       Date:  2021-03-18       Impact factor: 3.318

2.  Automatic Segmentation of Magnetic Resonance Images of Severe Patients with Advanced Liver Cancer and the Molecular Mechanism of Emodin-Induced Apoptosis of HepG2 Cells under the Deep Learning.

Authors:  Haiyan Zhao; Yuping Wang; Chen He; Jilin Yang; Yaoming Shi; Xiaolin Zhu
Journal:  J Healthc Eng       Date:  2022-03-07       Impact factor: 2.682
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.